• Japanese
  • Korean
  • Chinese
Cover Image

Nutrition and Vitamin Partnering 2009-2014

Nutrition & Vitamins Partnering 2009-2014 report provides understanding and access to the nutrition & vitamins partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in nutrition & vitamins partnering deals

Top nutrition & vitamins deals by value

Deals listed by company A-Z, industry sector, stage of development, technology type

Description

Nutrition & Vitamins Partnering 2009-2014 provides understanding and access to the nutrition & vitamins partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of nutrition & vitamins partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors nutrition & vitamins technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains over 220 links to online copies of actual liver disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of nutrition & vitamins partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in nutrition & vitamins partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading nutrition & vitamins deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of nutrition & vitamins partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the

research, development and commercialization of nutrition & vitamins technologies and products.

Report scope

Nutrition & Vitamins Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to nutrition & vitamins trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

  • Trends in nutrition & vitamins dealmaking in the biopharma industry since 2009
  • Access to summary headline, upfront, milestone and royalty data
  • The leading nutrition & vitamins deals by value since 2009

In Nutrition & Vitamins Partnering 2009-2014, the available deals are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Company A-Z
  • Industry sector
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Benefits

Nutrition & Vitamins Partnering 2009-2014 provides the reader with the following key benefits:

  • In-depth understanding of nutrition & vitamins deal trends since 2009
  • Access to summary headline, upfront, milestone and royalty data
  • Comprehensive access to over 220 actual nutrition & vitamins deals entered into by the world's biopharma companies since 2009
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in nutrition & vitamins partnering

  • 2.1. Introduction
  • 2.2. Nutrition & vitamins partnering over the years
  • 2.3. Bigpharma nutrition & vitamins dealmaking activity
  • 2.4. Nutrition & vitamins partnering by deal type
  • 2.5. Nutrition & vitamins partnering industry sector
  • 2.6. Nutrition & vitamins partnering by stage of development
  • 2.7. Nutrition & vitamins partnering by technology type
  • 2.8. Disclosed financial deal terms for nutrition & vitamins partnering
    • 2.8.1 Nutrition & vitamins headline values
    • 2.8.2 Nutrition & vitamins upfront payments
    • 2.8.3 Nutrition & vitamins milestone payments
    • 2.8.4 Nutrition & vitamins royalty rates

Chapter 3 - Leading nutrition & vitamins deals

  • 3.1. Introduction
  • 3.2. Top nutrition & vitamins deals by value
  • 3.3. Top nutrition & vitamins deals involving bigpharma

Chapter 4 - Dealmaking directory

  • 4.1. Introduction
  • 4.2. Company A-Z
  • 4.3. By deal type
  • Asset purchase
  • Bigpharma outlicensing
  • Co-development
  • Collaborative R&D
  • Co-market
  • Contract service
  • Co-promotion
  • CRADA
  • Cross-licensing
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Settlement
  • Spin out
  • Sub-license
  • Supply
  • Termination
  • 4.4. By industry sector
  • Academic
  • Bigpharma
  • Biotech
  • Drug delivery
  • Medical device
  • Diagnostic
  • Generic pharma
  • Government
  • Non-profit
  • Pharmaceutical
  • Research tools
  • Services
  • Specialty pharma
  • 4.5. By stage of development
  • Discovery
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Registration
  • Marketed
  • 4.6. By technology type
  • Analysis
  • Animal models
  • Assays
  • Bioinformatics
  • Biological compounds
  • Biomarkers
  • Biomaterials
  • Cell culture
  • Cell therapy
  • Clinical testing
  • Diagnostic - companion
  • Devices
  • Diagnostics
  • Discovery tools
  • DNA probes
  • Drug delivery
  • Enabling technology
  • Epigenetics
  • Equipment
  • Facilities
  • Gene therapy
  • Genomics
  • Imaging
  • Industrial chemicals
  • In vitro models
  • Monoclonal antibodies
  • Nanotechnology
  • Oligonucleotide
  • Peptides
  • Personalised medicine
  • Processes
  • Proteomics
  • Radio/Chemo-therapy
  • Recombinant DNA
  • Research services
  • Research supplies
  • RNA therapeutics
  • Screening
  • Small molecules
  • Stem cells
  • Vaccines

Chapter 5 - Partnering resource center

  • 5.1. Online partnering
  • 5.2. Partnering events
  • 5.3. Further reading on dealmaking

Appendices

  • Appendix 1 - Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering
  • Order Form - Reports
  • Table of figures
  • Figure 1: Nutrition & vitamins partnering since 2009
  • Figure 2: Bigpharma - top 50 - nutrition & vitamins deals 2009 to 2011
  • Figure 3: Bigpharma nutrition & vitamins deal frequency - 2009 to 2011
  • Figure 4: Nutrition & vitamins partnering by deal type since 2009
  • Figure 5: Nutrition & vitamins partnering by industry sector since 2009
  • Figure 6: Nutrition & vitamins partnering by stage of development since 2009
  • Figure 7: Nutrition & vitamins partnering by technology type since 2009
  • Figure 8: Nutrition & vitamins deals with a headline value
  • Figure 9: Nutrition & vitamins deals with upfront payment values
  • Figure 10: Nutrition & vitamins deals with milestone payments
  • Figure 11: Nutrition & vitamins deals with royalty rates, %
  • Figure 12: Top nutrition & vitamins deals by value since 2009
  • Figure 13: Top nutrition & vitamins deals signed by bigpharma value since 2009
  • Figure 14: Online partnering resources
  • Figure 15: Forthcoming partnering events
  • Figure 16: Deal type definitions
  • $1,695: single-user
  • $2,595: multi-user
  • $5,095: single site license
  • $8,475: global site license
  • An annual subscription to quarterly updates can be purchased for a small additional fee; ensuring you are kept up-to-date with the very latest nutrition & vitamins partnering deals. Quarterly updates available from $847.50.
  • A full explanation of license type definitions can be found here.
  • An additional $500 per copy will be added for full print and CD-ROM requests.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in nutrition & vitamins partnering

  • 2.1. Introduction
  • 2.2. Nutrition & vitamins partnering over the years
  • 2.3. Bigpharma nutrition & vitamins dealmaking activity
  • 2.4. Nutrition & vitamins partnering by deal type
  • 2.5. Nutrition & vitamins partnering industry sector
  • 2.6. Nutrition & vitamins partnering by stage of development
  • 2.7. Nutrition & vitamins partnering by technology type
  • 2.8. Disclosed financial deal terms for nutrition & vitamins partnering
  • 2.8.1 Nutrition & vitamins headline values
  • 2.8.2 Nutrition & vitamins upfront payments
  • 2.8.3 Nutrition & vitamins milestone payments
  • 2.8.4 Nutrition & vitamins royalty rates

Chapter 3 - Leading nutrition & vitamins deals

  • 3.1. Introduction
  • 3.2. Top nutrition & vitamins deals by value
  • 3.3. Top nutrition & vitamins deals involving bigpharma

Chapter 4 - Dealmaking directory

  • 4.1. Introduction
  • 4.2. Company A-Z
  • 4.3. By deal type
  • Asset purchase
  • Bigpharma outlicensing
  • Co-development
  • Collaborative R&D
  • Co-market
  • Contract service
  • Co-promotion
  • CRADA
  • Cross-licensing
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Settlement
  • Spin out
  • Sub-license
  • Supply
  • Termination
  • 4.4. By industry sector
  • Academic
  • Bigpharma
  • Biotech
  • Drug delivery
  • Medical device
  • Diagnostic
  • Generic pharma
  • Government
  • Non-profit
  • Pharmaceutical
  • Research tools
  • Services
  • Specialty pharma
  • 4.5. By stage of development
  • Discovery
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Registration
  • Marketed
  • 4.6. By technology type
  • Analysis
  • Animal models
  • Assays
  • Bioinformatics
  • Biological compounds
  • Biomarkers
  • Biomaterials
  • Cell culture
  • Cell therapy
  • Clinical testing
  • Diagnostic - companion
  • Devices
  • Diagnostics
  • Discovery tools
  • DNA probes
  • Drug delivery
  • Enabling technology
  • Epigenetics
  • Equipment
  • Facilities
  • Gene therapy
  • Genomics
  • Imaging
  • Industrial chemicals
  • In vitro models
  • Monoclonal antibodies
  • Nanotechnology
  • Oligonucleotide
  • Peptides
  • Personalised medicine
  • Processes
  • Proteomics
  • Radio/Chemo-therapy
  • Recombinant DNA
  • Research services
  • Research supplies
  • RNA therapeutics
  • Screening
  • Small molecules
  • Stem cells
  • Vaccines

Chapter 5 - Partnering resource center

  • 5.1. Online partnering
  • 5.2. Partnering events
  • 5.3. Further reading on dealmaking

Appendices

  • Appendix 1 - Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering
  • Order Form - Reports
  • Table of figures
  • Figure 1: Nutrition & vitamins partnering since 2009
  • Figure 2: Bigpharma - top 50 - nutrition & vitamins deals 2009 to 2014
  • Figure 3: Bigpharma nutrition & vitamins deal frequency - 2009 to 2014
  • Figure 4: Nutrition & vitamins partnering by deal type since 2009
  • Figure 5: Nutrition & vitamins partnering by industry sector since 2009
  • Figure 6: Nutrition & vitamins partnering by stage of development since 2009
  • Figure 7: Nutrition & vitamins partnering by technology type since 2009
  • Figure 8: Nutrition & vitamins deals with a headline value
  • Figure 9: Nutrition & vitamins deals with upfront payment values
  • Figure 10: Nutrition & vitamins deals with milestone payments
  • Figure 11: Nutrition & vitamins deals with royalty rates, %
  • Figure 12: Top nutrition & vitamins deals by value since 2009
  • Figure 13: Top nutrition & vitamins deals signed by bigpharma value since 2009
  • Figure 14: Online partnering resources
  • Figure 15: Forthcoming partnering events
  • Figure 16: Deal type definitions
Show More
Pricing
Get Notified
Email me when related reports are published